Cotización Mirum Pharmaceuticals - MIRM

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

42.65

Postura de Compra

41.50

Postura de Venta

46.52

Volume Operado de la Acción

279,097

41.58 Rango del Día 42.845

23.14 Rango de 52 semanas 48.89

Capitalización de Mercado [m]

2.047B

Precio Anterior

42.39

Precio de Apertura

41.85

Hora

42.65

Última hora de negociación

Volumen financiero

US$ 11,820,926

Precio Promedio Ponderado

42.3542

Volumen promedio (3 m)

360,792

Acciones en circulación

48,004,582

Rendimiento del Dividendo

Ratio Precio/Utilidad

-12.52

Beneficio por acción (BPA)

-3.4

turnover

186.37M

Beneficio neto

-163.42M

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC... Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sede

Dover, Delaware, USA

Fundado

Mirum Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MIRM. The last closing price for Mirum Pharmaceuticals was US$42.39. Over the last year, Mirum Pharmaceuticals shares have traded in a share price range of US$ 23.14 to US$ 48.89.

Mirum Pharmaceuticals currently has 48,004,582 shares in issue. The market capitalisation of Mirum Pharmaceuticals is US$2.03 billion. Mirum Pharmaceuticals has a price to earnings ratio (PE ratio) of -12.52.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.49	-1.13583681038	43.14	45.03	41.6	482624	43.06527279	CS
4	1.13	2.72157996146	41.52	47.08	41.0504	365375	44.02916858	CS
12	3.62	9.27491673072	39.03	48.89	37.51	360792	41.82738998	CS
26	15.05	54.5289855072	27.6	48.89	27.1	531418	39.07929118	CS
52	15.28	55.8275484107	27.37	48.89	23.14	550179	32.87823478	CS
156	27.84	187.981093856	14.81	48.89	14.63	440012	28.38566582	CS
260	25.31	145.963091119	17.34	48.89	9.14	317239	26.69862402	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
NUKKNukkleus Inc	US$ 11.655 (738.49%)	174.06M
PRTGPortage Biotech Inc	US$ 8.8678 (172.86%)	36.23M
OPTXSyntec Optics Holdings Inc	US$ 3.55 (99.44%)	92.44M
PTPIPetros Pharmaceuticals Inc	US$ 0.4976 (86.37%)	63.36M
LUXHLuxUrban Hotels Inc	US$ 0.849899 (59.67%)	29.51M
VCNXVaccinex Inc	US$ 1.41 (-61.37%)	758.95k
TNYATenaya Therapeutics Inc	US$ 1.395 (-51.56%)	42.45M
ORKTOrangeKloud Technology Inc	US$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	US$ 1.395 (-39.35%)	18.16M
DBGIDigital Brands Group Inc	US$ 2.46 (-37.88%)	805.23k
RIMEAlgorhythm Holdings Inc	US$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.335 (-36.79%)	1.02B
GOEVCanoo Inc	US$ 0.118 (7.08%)	388.43M
NVDANVIDIA Corporation	US$ 130.39 (-1.22%)	259.4M
XTIAXTI Aerospace Inc	US$ 0.0442 (8.33%)	222.55M